605-7693 [email protected]

Total Page:16

File Type:pdf, Size:1020Kb

605-7693 Wendichason@Mountsinai.Org newswise.com/articles/mount-sinai’s-david-adams%2C-md%2C-named--2019-president-of-american-association-for- thoracic-surgery Contact: Wendi Chason Mount Sinai Press Office (646) 605-7693 [email protected] Mount Sinai’s David Adams, MD, Named 2019 President of American Association for Thoracic Surgery World-renowned mitral valve expert will lead the world's most prestigious organization of cardiovascular thoracic surgeons. Newswise — NEW York, NY (MAY 2, 2018) David H. Adams, MD, the Marie-Josée and Henry R. Kravis Professor and Chair of the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai and Cardiac Surgeon-in-Chief of the Mount Sinai Health System, will be named President of the American Association for Thoracic Surgery (AATS) at its 98th annual meeting on Saturday, April 28, in San Diego. “Dr. Adams is an internationally recognized leader in the field of heart valve surgery and mitral valve reconstruction, and we are proud that his achievements have been acknowledged by this prominent organization. As President, Dr. Adams will make significant contributions to the care and treatment of cardiothoracic disease throughout the world,” said Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System. “I am very proud of Dr. Adams, his significant contributions to the field, and his strong commitment to improving the field of cardiothoracic surgery at Mount Sinai and around the globe,” said Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, who serves as Editor-in-Chief of the Journal of the American College of Cardiology (JACC). “I have worked closely with Dr. Adams for many years and have always been impressed with his unwavering devotion to the highest level of patient care.” The AATS is an international organization of more than 1,300 of the world's foremost cardiothoracic surgeons representing 41 countries. Founded in 1917, the Association is committed to science, education, and research, as demonstrated by its Annual Meeting and its four official journals, the Journal of Thoracic and Cardiovascular Surgery, Seminars in Thoracic and Cardiovascular Surgery, Operative Techniques in Thoracic and Cardiovascular Surgery, and the Pediatric Cardiac Surgery Annual. As the Program Director of The Mount Sinai Hospital's Mitral Valve Repair Reference Center, Dr. Adams has set national benchmarks, with degenerative mitral valve repair rates of greater than 99 percent, while running one of the largest programs in the United States with a team that now performs more than 400 mitral valve operations per year. Dr. Adams is also President of the Mitral Foundation, a not-for-profit organization dedicated to promoting best practice 1/3 standards in mitral valve disease, and has co-authored, with Alain Carpentier, MD, PhD, the internationally acclaimed and widest-selling valve textbook, Carpentier's Reconstructive Valve Surgery. Dr. Adams is also the co-inventor of two mitral valve annuloplasty repair rings (the Carpentier- McCarthy-Adams IMR ETlogix Annuloplasty Ring and the Carpentier-Edwards Physio II Annuloplasty Ring), and is also the inventor of the Medtronic Tri-Ad Adams Tricuspid Annuloplasty Ring. He is a co-director of the annual American College of Cardiology/American Association for Thoracic Surgery Heart Valve Summit, and the Program Director of the biennial AATS Mitral Conclave, the largest international meeting in the world focused on mitral valve disease. An acclaimed speaker and educator, Dr. Adams has given more than 350 invited global lectures. His dedication to teaching surgery throughout the world is well known and he has performed surgery on more than 200 patients in China, the Dominican Republic, Germany, Indonesia, Japan, Poland, Thailand, and Vietnam. Dr. Adams’ major research interests include mitral valve repair outcomes, strategies in complex mitral valve repair, and transcatheter valve replacement. Past research honors include the Alton Ochsner Research Scholarship from the AATS and the Paul Dudley White Research Fellowship from the American Heart Association. He has also received honorary Professorships from Capital University in Beijing and Keio University in Tokyo. He has held his current position as Professor and Chair at the Icahn School of Medicine at Mount Sinai since 2002. About the Mount Sinai Health System The Mount Sinai Health System is New York City’s largest integrated delivery system encompassing seven hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai’s vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The System includes approximately 7,100 primary and specialty care physicians; 10 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools”, aligned with a U.S. News & World Report’s “Honor Roll” Hospital, No. 13 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report’s “Honor Roll” of top U.S. hospitals; it is one of the nation’s top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in four other specialties in the 2017-2018 “Best Hospitals” issue. Mount Sinai’s Kravis Children’s Hospital also is ranked in six 2/3 out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and 50th for Ear, Nose, and Throat, while Mount Sinai Beth Israel, Mount Sinai St. Luke’s and Mount Sinai West are ranked regionally. For more information, visit http://www.mountsinai.org/, or find Mount Sinai on Facebook, Twitter and YouTube. # # # 3/3.
Recommended publications
  • Ahmed Mohamed Fahmy Elwatidy, Md, Ms, Frcs
    AHMED MOHAMED FAHMY ELWATIDY, MD, MS, FRCS, PhD Contact: +201146921922, +201282275517 | Email: [email protected] Professional Links: http://www.ctsnet.org/home/aelwatidy | https://www.linkedin.com/in/ahmed-elwatidy-23a8b826 | https://www.youtube.com/user/DrWatidy, https://www.researchgate.net/profile/Ahmed_Elwatidy PROFILE SUMMARY Cardiac Surgeon with 30 years of experience in management of cardiothoracic surgery patients. Handling all aspects of perioperative cardiac care from daily rounds to major cardiac surgical procedures, including postoperative intensive care management. With the merit of performing more than 5000 cardiac surgery operations; Coronary artery Bypass surgeries, all types of valve replacement surgeries, mitral and tricuspid repairs, Atrial fibrillation surgery (AF Ablation), Redo valve and coronary surgeries, heart failure surgery, left ventricular restoration, minimally invasive mitral and tricuspid surgery, TAVI and Aortic aneurysm surgery. Gained experience in Paediatric Cardiac Surgery including ASD, VSD, TOF, AVC, Aortic coarctation repair, and valve repair in grown up kids, PDA and PS. Senior decision-making capabilities especially during emergency situations and administrative Expertise as a director of cardiac center of excellence, and head of department of cardiac surgery. Active academically as a clinical associate professor, and investigator of many research projects. Innovator of many patent technologies and novel surgical techniques. Core Competencies: Coronary artery Bypass Surgery, Valve Replacement
    [Show full text]
  • A Challenge a Most- Deserved Honour
    VOL 6 NO 3 AUTUMN 2007 Promoting Cardiovascular Education, Research and Patient Care In This Issue A Challenge 37 A Challenge Over the past 10 years, the A Most- 37 A Most-Deserved Honour Academy has built a base Deserved 38 Executive Committe for international connectiv- ity for promoting cardiovas- 40 Reports from Japan Meeting Honour cular health. This has been 41 Doctor Receives Volvos for Life “HOUSTON -- (October 2, 2007) achieved by establishing Legislation authorizing a Congres- 42 XVII Brazil Forum seven sections and hold- sional Gold Medal for Dr. Michael 43 Lasker Award for Development ing a variety of workshops, E. DeBakey, pioneering heart sur- of Prosthetic Heart Valves symposia and conferences geon and chancellor emeritus of 44 Indian First-in-man Trials all over the world as well as Baylor College of Medicine, is on 47 Turkey Symposium having several publications its way to President George W. and its own website. 48 John Madden’s “Coach’s Corner” Bush for his signature. Currently, the Academy is proposing to promote link- 49 Mendel Symposium II The U.S. Congress today ap- ages among cardiovascular institutes and centres in proved the bill that now will be 50 Dr. William Parmley the area of population health, clinical studies, scientific forwarded to the president. U.S. 50 Dr. Bohdan Lewartowski investigations, prevention and education for improving Senator Kay Bailey Hutchison and 51 Dr. Sergio Dalla-Volta cardiovascular health. This could help facilitate exchang- U.S. Reps. Al Green, Michael Bur- 52 Dr. Garrett Gross es of health professionals and foster collaborations.
    [Show full text]
  • Nature Medicine Essay
    LASKER CLINICAL MEDICAL RESEARCH AWARD COMMENTARY The surprising rise of nonthrombogenic valvular surgery Alain Carpentier Surgery has always been regarded as an art rather than a science—the art of curing dis- eases by manipulating instruments with one’s hands. In the past, progress resulted from the development of new ways of cutting, excising, resealing and suturing. Nowadays, this is no longer the case. My own specialty—cardiac surgery—did not exist 60 years ago. Its spectacular devel- opment would not have been possible with- out the contribution of basic sciences and engineering. Surgeons who participated in its development had to master these sciences. A visit to a cardiac surgery operating room may give an idea of the influence of these dis- ciplines. In a 50-square-meter room, a patient is lying on the operating table with his chest open and his beating heart exposed to the dazzling light of three “suns of crystal”, as Figure 1 First (homemade) glutaraldehyde-treated pig valve implanted in human. Left, Teflon-covered Paul Valery named the operating lights hang- stainless steel stent used to support the valve, preventing its deformation during implantation. Right, ing from the ceiling. Around the table, ten stent covered with Dacron fabric to facilitate fixation and host-tissue incorporation. The porcine valve phantom-like people, dressed from head to has been sutured into the stent preserving a full motion of the leaflets, avoiding fibrous incorporation. feet in blue gowns, bustle about, exchanging From ref. 6. few words. The patient’s life hangs on sophis- ticated machinery. Multiple tubes, wires, makers, defibrillators or cardiac-valve pros- that her life could be saved by oxygenating catheters connect him to monitoring devices, theses of different types are also available.
    [Show full text]
  • Premier Visits Iraq in Sign of Warming Ties
    SUBSCRIPTION THURSDAY, JUNE 13, 2013 SHAABAN 4, 1434 AH www.kuwaittimes.net Philippines Greece in Syrian soap Messi and Embassy crisis over recreates father accused celebrates state TV Damascus in of tax fraud 115th I-Day5 closure21 Gulf40 desert in19 Spain Premier visits Iraq in Max 43º Min 29º sign of warming ties High Tide 03:37 & 13:47 Leaders sign accords, discuss Syria, war reparations Low Tide 08:35 & 21:16 40 PAGES NO: 15838 150 FILS BAGHDAD: Kuwait’s prime minister discussed ties with conspiracy theories his Iraqi counterpart in Baghdad yesterday during a sur- prise one-day visit, signaling improving relations between neighbors still working to overcome the more Electricity, than two-decade legacy of war. The warming bonds between Iraq and Kuwait is noteworthy in a region sweet simplicity increasingly plagued by the sectarian divisions running through Syria’s civil war and Iraq, which is struggling to contain its worst eruption of violence in years. Iraqi Prime Minister Nouri Al-Maliki personally greeted Sheikh Jaber Al-Mubarak Al-Sabah on a red carpet on the airport tarmac yesterday before the two men sat By Badrya Darwish down for talks. Officials later signed a series of agree- ments aimed at improving bilateral ties in the econom- ic, transportation and other sectors. Continued on Page 15 [email protected] Co-ops boycott Iran KUWAIT: Several Kuwaiti supermarket chains have lectricity, electricity, sweet simplicity. This ad begun boycotting products from Iran for its support slogan is stuck in my mind since the good old of the Syrian regime, while activists staged a demon- stration against the involvement of the Lebanese Edays in London.
    [Show full text]
  • Event Programme
    Event Programme 2nd - 4th December 2017 | Groote Schuur Hospital, University of Cape Town Welcome Dear Colleague, It gives us great pleasure to welcome you to the 50th Anniversary of the world’s first heart transplant! On the 3rd December 2017 it will be the 50th anniversary of the world’s first human to human heart transplant performed by Christiaan Barnard and his team in our Department at Groote Schuur Hospital and the University of Cape Town. This was an iconic world event which captured the attention of the public and world media like no other medical advance before it,and continues to be the world’s most publicised medical event of all time. The only other comparable world iconic event of that era, and which similarly caught the attention of the world, was the Apollo landing on the moon 18 months later in July 1969. Apart from our focus on celebrating medical advances, we wish to broaden our scope to include other innovative and courageous developments, which have similarly advanced the scope and horizons of modern human endeavour. We also wish to focus on how the great advances in medicine which were pioneered, developed and commercialized by the various pharmaceutical and medical device companies, can be expanded to reach the underprivileged areas of the world where there is such a burden of cardiovascular disease. Presently the large expense of most of these recent developments preclude their widespread use (or penetration) in the developing economies of the world We would like to thank some of the leading Cardiovascular Device- and Pharmaceutical companies whose CEO’s or senior staff will be joining us in the debate around how modern cardiovascular interventions can be provided to the large areas of the world where there is at present such a dearth of cardiovascular healthcare.
    [Show full text]
  • Event Programme
    Event Programme 2nd - 4th December 2017 | Groote Schuur Hospital, University of Cape Town Welcome Dear Colleague, It gives us great pleasure to welcome you to the 50th Anniversary of the world’s first heart transplant! On the 3rd December 2017 it will be the 50th anniversary of the world’s first human to human heart transplant performed by Christiaan Barnard and his team in our Department at Groote Schuur Hospital and the University of Cape Town. This was an iconic world event which captured the attention of the public and world media like no other medical advance before it,and continues to be the world’s most publicised medical event of all time. The only other comparable world iconic event of that era, and which similarly caught the attention of the world, was the Apollo landing on the moon 18 months later in July 1969. Apart from our focus on celebrating medical advances, we wish to broaden our scope to include other innovative and courageous developments, which have similarly advanced the scope and horizons of modern human endeavour. We also wish to focus on how the great advances in medicine which were pioneered, developed and commercialized by the various pharmaceutical and medical device companies, can be expanded to reach the underprivileged areas of the world where there is such a burden of cardiovascular disease. Presently the large expense of most of these recent developments preclude their widespread use (or penetration) in the developing economies of the world We would like to thank some of the leading Cardiovascular Device- and Pharmaceutical companies whose CEO’s or senior staff will be joining us in the debate around how modern cardiovascular interventions can be provided to the large areas of the world where there is at present such a dearth of cardiovascular healthcare.
    [Show full text]
  • CV of Alain Carpentier
    CURRICULUM VITAE ALAIN CARPENTIER, M.D, Ph.D. Born August 11, 1933 in Toulouse, France Married, 4 children Professional address : Département de Chirurgie Cardio-Vasculaire et de Transplantation d’Organes Hôpital Européen Georges Pompidou 20 rue Leblanc 75015 Paris, France. Tel. +33-1 56 09 36 01 Fax +33-1 56 09 36 04 Email [email protected] BACKGROUND AND FUNCTIONS Doctor of Medicine, University of Paris (1966). Doctor of Sciences (Ph.D.), University of Paris (1975). Founder and director of the "Laboratoire d'Etude des Greffes et Prothèses Cardiaques", University of Paris (since 1967). Professor of Cardiovascular Surgery, University of Paris (1978), Emeritus since 2004. Membre de l'Académie des Sciences, Institut de France (2000). Adjunct Professor, Mount Sinai School of Medicine New York (2002). President, Académie des Sciences, Institut de France (since 2011). Chief Department of Cardiovascular Surgery and Organ Transplantation, Hôpital Broussais- Hôpital Européen Georges Pompidou (1982-2000). Consultant Hôpital Européen Georges Pompidou (since 2000). International "Visiting Professor" University of New-York (1983, 2001-2005), Portland (1986-1989), London (1989, 1996-2002), Harvard (1991, 1996, 2002, 2005), Montreal (1991, 2004, 2005, 2006), Baylor (2002), Washington (1994, 2000), Florida (1996, 1999), Padua (1996), Beirut(1996), Virginia (1997), North Carolina (1998), Tokyo (1998, 2000, 2003), Bangkok (2000, 2004), Pavia (2000), Buffalo (2001), Belgrade (2003), Philadelphia (2004), Mexico (2004), Minneapolis (2004), Delhi (2006), Morioka (2006), Jerusalem (2007). Scientific Advisor : Edwards LifeSciences Research and Development, Irvine, California (since 1975). 1 ORIGINAL SCIENTIFIC WORKS The concept and development of valvular bioprosthesis (Biological valve of animal origin chemically treated to avoid immunological rejection) : Discovery that Glutaraldehyde reduces xenograft tissue antigenicity and enhances tissue stability by crosslinkages.
    [Show full text]
  • N Tim Institut Du Coeur: Success of a Congenital Heart Disease Center in a Developing Country
    Annals of Global Health VOL. 82, NO. 4, 2016 ª 2016 Published by Elsevier Inc. on behalf of Icahn School of Medicine at Mount Sinai. ISSN 2214-9996/$36.00 http://dx.doi.org/10.1016/j.aogh.2016.08.002 VIEWPOINT Viện Tim Institut du Coeur: Success of a Congenital Heart Disease Center in a Developing Country Paul S. Lajos, MD, Alain F. Carpentier, MD, PhD New York, NY; Paris, France Abstract OBJECTIVE The goal of the Viện Tim Institute du Coeur is to provide high quality cardiac surgical care to the Vietnamese population with 25% of care allocated to the indigent. This article discusses the history; functional and financial implementation of creating a long-term fully sustainable adult and pediatric cardiac surgery center in Southeast Asia in a developing country. METHODS The Institut du Coeur in Ho Chi Minh City, Vietnam is a fully functional and financially solvent cardiac surgery center that was formed 28 years ago. It was borne from the Alain Carpentier Foundation which oversees its activity and the Centre Médical International which is an outpatient clinic in Ho Chi Minh City and continues to financially support and oversee the development and future of the Institute. This article details many of the key components to the development of this sustainable pro- gram and its evolution. RESULTS Since 1996, over 25,000 patients with complicated adult and congenital cardiac disease have been treated at the infirmary with support from the Alain Carpentier Foundation since it was established in 1992. The hospital has also performed surgery and treatment to poor patients across Vietnam with over 6,700 impoverished patients having had free operations with an estimated cost of VND230 billion (US$10.2 million).
    [Show full text]
  • Investor Presentation
    SAVE AND IMPROVE PATIENTS’ LIVES WITH DISRUPTIVE PROSTHESES INITIAL PUBLIC OFFERING PROJECT ON EURONEXT PARIS REGULATED MARKET Disclaimer IMPORTANT NOTICE - YOU MUST READ THE FOLLOWING BEFORE CONTINUING The following applies to this document, the oral presentation of the information in this such information or statistics should not be interpreted as having been adopted or endorsed clients, or for advising any such person in relation to the contents of the Information or in document by Affluent Medical (the “Company”) or any person on behalf of the Company and by any of the Company, the Banks, their affiliates or any of their officers, directors, connection with the Proposed Transaction. any question-and-answer session that follows the oral presentation (collectively, the employees, agents or advisers as being accurate. All statements in this report attributable to The Information does not constitute or form part of a prospectus or any offer or invitation “Information”). This document has been prepared by the Company and certain affiliated third party industry experts represent the Group’s interpretation of data, research opinion or for the sale or issue of, or any offer or inducement to purchase or subscribe for, or any companies (together, the “Group”). viewpoints published by such industry experts, and have not been reviewed by them. Each solicitation of any offer to purchase or subscribe for any shares or other securities in the By attending the meeting where this presentation is made, or by reading this document, you publication of such industry experts speaks as of its original publication date and not as of the Company in France, the United Kingdom, the United States or any other jurisdiction.
    [Show full text]
  • C.V. De Alain Carpentier
    CURRICULUM VITAE Dr Alain CARPENTIER Date de naissance 11 août 1933 Lieu de naissance Toulouse, 31000 France Nationalité Française Situation de famille Marié, quatre enfants Adresse Hôpital Européen Georges Pompidou Département de Chirurgie Cardio-Vasculaire et de Transplantation d’Organes 20, rue Leblanc – 75015 Paris Téléphone 01 56 09 36 01 Télécopie 01 56 09 36 04 E-mail [email protected] TITRES ET FONCTIONS UNIVERSITAIRES ET ACADEMIQUES Docteur en Médecine, 1966 Docteur ès Sciences, Doctorat d’Etat, 1975 Professeur des Universités (Paris 6), 1978 – Emérite depuis 2004 Professeur au Mount Sinai School of Medicine, New York University, depuis 2002 Membre de l’Institut (Académie des Sciences), 2000 Président de l’Académie des Sciences, depuis 2011 Enseignant comme "visiting professor" des Universités de New York (1983, 2001-2005), Portland (1986,1989), Londres (1989, 1996-2002), Harvard (1991, 1996, 2002, 2005), Montréal (1991, 2004, 2005, 2006), Baylor (1992), Washington (1994, 2000), Floride (1996, 1999), Padoue (1996), Beyrouth (1996, 2009), Virginie (1997), North Carolina (1998), Tokyo (1998, 2000, 2003), Bangkok (2000, 2004), Pavie (2000), Buffalo (2001), Belgrade (2003), Philadelphie (2004), Mexico (2004), Minneapolis (2004), Delhi (2006), Morioka (2006), Jérusalem (2007), Taipei (2009), Chicago (2009). TITRES ET FONCTIONS HOSPITALIERES Interne des Hôpitaux de Paris, 1961 Chef de clinique assistant des Hôpitaux de Paris, 1966 Chirurgien des Hôpitaux de Paris, 1972 Chef du Département de Chirurgie Cardio-vasculaire
    [Show full text]
  • Aere Eaere Program
    PROGRAM Julie Armstrong AERE EAERE2002 2ND WORLD CONGRESS OF ENVIRONMENTAL AND RESOURCE ECONOMISTS Monterey, CA USA June 24-27, 2002 AERE EAERE2002 2ND WORLD CONGRESS OF ENVIRONMENTAL AND RESOURCE ECONOMISTS Monterey, CA USA June 24-27, 2002 PROGRAM The photograph on the cover of the Program Book shows the Big Sur coastline. The photograph on the cover of the Book of Abstracts shows the Carmel Mission. The tree shown on the title page is an artist’s rendition of the Lone Cypress, viewed from the 17 Mile Drive in Pebble Beach. CONTENTS Welcome to the 2nd World Congress …………………………… 2 Welcome to Monterey …………………………………………… 3 Congress Sponsors .……………………………………………… 4 Acknowledgments ………………………………………………. 5 Congress Committees …………………………………………… 6 Map of Monterey Area …………………………………………. 10 Congress Information Location …………………………………………………. 11 Public Parking …………………………………………… 11 Registration ……………………………………………… 11 Congress Secretariat …………………………………….. 12 Information Desk ……………………………………….. 12 Message Board …………………………………………. 12 Identification Badges …………………………………… 12 Location of Sessions ……………………………………. 12 Exhibits …………………………………………………. 12 Map with Location of Meeting Rooms ………………… 13 Coffee Breaks …………………………………………. 14 Lunch ………………………………………………….. 14 Internet Access ………………………………………… 14 Photocopying ………………………………………….. 14 Banks/Post Office ……………………………………… 14 Social Activities Gala Dinner ……………………………………………. 15 Eating and Drinking …………………………………… 16 Local Activities ………………………………………… 16 Side Trips and Other Travel …………………………… 16 Congress Program Schedule of
    [Show full text]